RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TH1902 ClinicalTrials.gov UpdateBy definition, a hostile takeover is never governed by a due diligence to start with, it is bases on information available on the market for this company and i believe there is sufficient information to make a low ball offer that would be of interest to shareholders. From my understanding Thera as at least a base market value of 2.05 usd.